Bausch Health Companies (BHC) announced the appointment of Michael Goettler and Sandra Leung to its Board of Directors, effective July 22, 2025. The appointments increase the size of the Board from ten to twelve members. Most recently, Goettler served as CEO of Viatris (VTRS). Sandra Leung brings decades of experience and insight from her distinguished career in the pharmaceutical industry, most recently as EVP and General Counsel of Bristol Myers Squibb (BMY).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC: